(Q33393304)

26 July 2017

title

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome (English)

1 reference

atypical hemolytic uremic syndrome

26 July 2017

1 reference

1 reference

Véronique Frémeaux-Bacchi

inferred from title

author

series ordinal

2

object named as

Véronique Frémeaux-Bacchi

1 reference

26 July 2017

author name string

Anne-Laure Lapeyraque

series ordinal

1

1 reference

26 July 2017

Pierre Robitaille

series ordinal

3

1 reference

26 July 2017

language of work or name

1 reference

15 December 2010

1 reference

26 July 2017

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

621-624

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-010-1719-3

26 July 2017

exact match

0 references

cites work

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Secondary failure of plasma therapy in factor H deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Atypical haemolytic uraemic syndrome and mutations in complement regulator genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Eculizumab for congenital atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Eculizumab for Atypical Hemolytic–Uremic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1719-3

Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21161283

12 December 2020

inferred from PubMed ID database lookup

Genetic studies into inherited and sporadic hemolytic uremic syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21161283

12 December 2020

inferred from PubMed ID database lookup

Atypical relapse of hemolytic uremic syndrome after transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21161283

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00467-010-1719-3

1 reference

Dimensions Publication ID

26 July 2017

1041965620

0 references

1 reference